Recent studies suggest that ACPA may directly play an active role in RA pathogenesis, as ACPA have been shown to mediate bone loss, pain, and enhance arthritis in vivo (2–6), as well as inducing pro-inflammatory events in different in vitro cell systems (3, 4, 7–11). Here, PRTN3 is linked to Arthritis.